Literature DB >> 15080372

Effects of a low dose of indapamide, a diuretic, given daily or every-other-day on blood pressure and metabolic parameters.

Munemichi Inaba1, Yuichi Noguchi, Taro Yamamoto, Tomihiko Imai, Masako Hatano, Shinji Yagi, Shigehiro Katayama.   

Abstract

To investigate the effects of the diuretic, indapamide, on blood pressure (BP) and metabolic parameters, thirty hypertensive patients were treated with 1 mg of indapamide either every day or every other day. BP, fasting plasma glucose, lipids, serum potassium and uric acid were determined at baseline and after 3 months of a stable regimen of the drug. At the termination of the study, 48-h ambulatory blood pressure monitoring (ABPM) was performed. Three patients received only indapamide, while other patients were treated in combination with additional antihypertensive medications. Patients treated with daily indapamide showed a BP reduction from 162 +/- 2.9/85 +/- 2.4 mmHg to 134 +/- 2.4/71 +/-2.6 mmHg (p < 0.001). The BP reduction was similar in those patients receiving the drug every other day (137 +/- 3.4/71 +/- 3.6 mmHg). While plasma lipids and serum potassium did not differ significantly with the intervention, uric acid increased significantly with daily treatment and normalized with every-other-day treatment. Glycosylated hemoglobin A1c (HbA1c) was not altered (5.6 +/- 0.1% vs. 5.4 +/- 0.2%), and did not differ between patients with and without diabetes mellitus. ABPM revealed an average 24-h BP of 134 +/- 3.3/75 +/- 1.7 mmHg on days in which patients received the medication and 139 +/- 4.9/78 +/- 2.6 mmHg on the intervening day without indapamide (no significant difference). These results suggest that a low dose of indapamide given every day or every other day is effective in lowering BP and does not result in metabolic derangements.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15080372     DOI: 10.1291/hypres.27.141

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  3 in total

1.  The effects of increasing calcium channel blocker dose vs. adding a diuretic to treatment regimens for patients with uncontrolled hypertension.

Authors:  Shigemasa Tani; Kei Asayama; Koji Oiwa; Shinsuke Harasawa; Katsuaki Okubo; Atsuhiko Takahashi; Ayumi Tanabe; Takayoshi Ohkubo; Atsushi Hirayama; Toshio Kushiro
Journal:  Hypertens Res       Date:  2017-04-27       Impact factor: 3.872

2.  The Na+-excreting efficacy of indapamide in combination with furosemide in massive edema.

Authors:  Misa Tanaka; Emi Oida; Keiko Nomura; Fumiaki Nogaki; Atsushi Fukatsu; Kazuhide Uemura; Masatomo Yashiro; Takeshi Kimura; Eri Muso; Takahiko Ono
Journal:  Clin Exp Nephrol       Date:  2005-06       Impact factor: 2.801

3.  Chemical stability and interactions in a new antihypertensive mixture containing indapamide and dihydralazine using FT-IR, HPLC and LC-MS methods.

Authors:  Anna Gumieniczek; Justyna Galeza; Anna Berecka; Tomasz Mroczek; Krzysztof Wojtanowski; Katarzyna Lipska; Joanna Skarbek
Journal:  RSC Adv       Date:  2018-10-23       Impact factor: 4.036

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.